This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment of salmonellosis

Authoring team

Salmonella spp (nontyphoidal)

  • antibiotic therapy is indicated only in high-risk children to reduce the risk of bacteraemia and extra-intestinal focal infections
  • antibiotics recommended to treat adults include a fluoroquinolone (e.g., ciprofloxacin) or azithromycin depending on the local susceptibility patterns and travel history (1)
  • preferred therapy – ceftriaxone
  • alternative agents - azithromycin, ciprofloxacin (1)

Salmonella typhi

  • preferred therapy – third-generation cephalosporins
  • alternative agents - chloramphenicol (1)

The typical antibiotic course is for 3 to 7 days or until after fevers resolve (2)

Salmonellosis is a notifiable disease

References:

  1. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):1963-73.
  2. Gilbert DN, Chambers HF, Eliopoulos GM, et al. The Sanford guide to antimicrobial therapy, 47th ed. Sperryville, VA: Antimicrobial Therapy, Inc.; 2017.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.